Volume 20 No 10 (2022)
 Download PDF
Personalized Medicine &Pharmacogenomics: Milestone in Treatment Approach from Traditional to Modern Way
Kunal Kanojia , Shubham Bhatt , Anuj Pathak , Dr. Daksh Bhatia , Dr.Abhay Bhardwaj, Dr. Parul Grover , Dr. Mandeep Arora
Abstract
Daily changes in the lifestyle caused so many imbalances in the health condition and using the same medication for all ones is not good. So we approach the modern way in which the treatment is based on the gene studies of a particular person to develop new techniques to treat the diseased condition and prescribed them the best medications that optimized their health perfectly. All the individuals have different gene profiles which makes them venerable and the basis on which we develop these personalized medicines. This genomic portfolio helps in developing the best, safe, and most effective treatment method for a particular person with their unique gene profile. The advancement in personalized medicine can help to detect the diseases at their previous stage with the help of different biomarkers and early detection of genetic events in diseased conditions. By developing this method, there area lot of limitations and challenges that occurred in the way to minimize them different standard measures were also taken to prevent the privacy of individuals. This modern approach provides different applications and benefits in the field of treatment. The detection of various genes is easy through the gene testing help in marking the genes through the biomarkers help to minimize the effect. Nowadays, personalized medicine is mostly preferred by people to treat not only the diseases but also the inherent problem too. Different studies were also performed on a population to get its importance from different scientists, doctors, and pharmacists, and in response that gets good response regarding using such a treatment approach to held. This method not only minimized the side effect of the drug but also guarantee a successful result in treatment.
Keywords
Biomarkers, Genomic portfolio, Gene testing, Personalized Medicine, Pharmacogenomic, Venerability
Copyright
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.